头颈癌重建手术中常规静脉血栓栓塞预防的合理性探讨
该回顾性研究分析了2008至2013年间1953例头颈癌切除并即刻重建患者,症状性静脉血栓栓塞(VTE)发生率为2.2%,死亡率为0.1%。结论认为皮瓣血栓预防方案可能对维持低VTE发生率起关键作用。
要点
- 症状性VTE发生率为2.2%,死亡率0.1%。
- 手术时间>592.5分钟、制动>4天及未行皮瓣血栓预防是VTE危险因素。
- 即使腓骨瓣重建患者制动时间延长,接受皮瓣血栓预防后VTE发生率仍低。
核心结论
- 皮瓣血栓预防方案可能对降低头颈癌重建术后VTE发生率起重要作用。
研究设计与样本
- 回顾性分析2008至2013年间连续接受头颈癌切除并即刻重建的1953例患者。
主要发现
- 症状性VTE发生率为2.2%,死亡率为0.1%。
关键数值与推荐
- 常规给予右旋糖酐和前列腺素E2(PGE2)作为皮瓣血栓预防。
临床怎么用
- 对于头颈癌重建手术患者,应考虑皮瓣血栓预防以降低VTE风险。
- 对手术时间长、制动时间长的患者应加强VTE风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venous thromboembolism (VTE) is a preventable complication in which early ambulation is expected after head and neck surgery. Thus, the role of VTE prophylaxis is questionable and needs further assessment. The purpose of this study was to specify the relative contributing risk factors for patients who underwent head and neck cancer ablation with immediate reconstruction. METHODS: A retrospective analysis was conducted of consecutive head and neck cancer ablations with immediate reconstructions between 2008 and 2013. Dextran and prostaglandin E2 (PGE2) were routinely given as flap thromboprophylaxis. Logistic regression was applied to analyze the potentially significant risk factors. RESULTS: Of 1953 subjects, the incidence of symptomatic VTE was 2.2% with 0.1% mortality rate. Prolonged surgery (>592.5 minutes; P = .048), immobilization (>4 days; P = .019), and subjects without postoperative flap thromboprophylaxis (P = .002) are significant risk factors for VTE development. CONCLUSION: Our flap thromboprophylaxis regime might have played a crucial role in keeping the incidence of VTE low. Despite prolonged immobilization in fibula flap reconstruction, the incidence of VTE remained low when flap thromboprophylaxis was given.
引用
- Ong HS, Gokavarapu S, Al-Qamachi L, et al. Justification of routine venous thromboembolism prophylaxis in head and neck cancer reconstructive surgery. Head Neck. 2017. PMID: 28963805. doi:10.1002/hed.24914
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。